novo nordisk - Search News

News

Novo Nordisk ousts CEO

The New York Times · 9h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Reuters on MSN · 7h

Novo Nordisk ousts CEO after falling behind in weight loss market

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

CEO of Novo Nordisk, maker of Wegovy, is stepping down

Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.

7hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

10h

Why Novo Nordisk Stock Just Slipped

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

12hon MSN

Talks to replace Novo Nordisk CEO lasted several weeks, board chair says

Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results